MedTrace Logo

Effects of Dextromethorphan on Opioid Tolerance in Methadone Patients - 1

NCT00000352 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2017-01-12

No results posted yet for this study

Summary

The purpose of this study is to determine if addition of dextromethorphan to a stable dose of methadone in opioid dependent subjects will significantly affect physical and psychological aspects of opioid tolerance.

Conditions

  • Opioid-Related Disorders
  • Substance-Related Disorders

Interventions

DRUG

Dextromethorphan

Sponsors & Collaborators

Principal Investigators

  • Charles O'Brien, M.D., Ph.D. · PDVAMC Treatment Research Center

Study Design

Purpose
TREATMENT

Eligibility

Min Age
21 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1996-12-31
Primary Completion
1998-02-28
Completion
1998-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00000352 on ClinicalTrials.gov